Skip to main content
. 2015 Feb 15;5(3):1089–1100.

Figure 3.

Figure 3

Disease-free survival (DFS) and overall survival (OS) rates were estimated by the Kaplan–Meier method. Both the (A) DFS rate and (B) OS rate of patients with MSI2 positive primary tumors was significantly lower than that of patients with MSI2 negative primary tumors (log-rank test, A: P = 0.002, B: P < 0.001).